【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Biologics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Advancements in biomedical science
3.1.1.2 Rise in biologics contract manufacturing services
3.1.1.3 Several drugs going off patents
3.1.1.4 Commercial success of biologics
3.1.2 Market Restraint Analysis
3.1.2.1 Pharmacokinetics challenges associated with biologics
3.1.2.2 Rising control & cost for accessing biologics
3.1.2.3 Development of biosimilars
3.2 Penetration & Growth Prospect Mapping for Product, 2016
3.3 Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Biologics: Pipeline Analysis
Chapter 4 Biologics Market: Source Estimates & Trend Analysis
4.1 Global Biologics Market: Source Movement Analysis
4.2 Microbial Source
4.2.1 Global microbial source market, 2014 – 2025 (USD Billion)
4.3 Mammalian Source
4.3.1 Global mammalian source market, 2014 – 2025 (USD Billion)
4.4 Others
4.4.1 Global other source market, 2014 – 2025 (USD Billion)
Chapter 5 Biologics Market: Product Estimates & Trend Analysis
5.1 Global Biologics Market: Product Movement Analysis
5.2 Monoclonal Antibodies
5.2.1 Global monoclonal antibodies market, 2014 – 2025 (USD Billion)
5.2.2 Monoclonal antibodies by application
5.2.2.1 Diagnostic monoclonal antibodies
5.2.2.1.1 Diagnostic MABs market, 2014 – 2025 (USD Billion)
5.2.2.1.2 Diagnostic MABs for biochemical analysis
5.2.2.1.3 Diagnostic MABs for imaging
5.2.2.2 Therapeutic MABs
5.2.2.2.1 Therapeutic MABs market, 2014 – 2025 (USD Billion)
5.2.2.2.2 Direct MABs
5.2.2.2.3 Targeting MABs
5.2.2.3 Protein purification MABs
5.2.2.3.1 Protein purification MABs market, 2014 – 2025 (USD Billion)
5.2.2.4 Other MABs
5.2.2.4.1 Other MABs market, 2014 – 2025 (USD Billion)
5.2.3 Monoclonal antibodies by type
5.2.3.1 Murine MABs
5.2.3.1.1 Murine MABs market, 2014 – 2025 (USD Billion)
5.2.3.2 Chimeric MABs
5.2.3.2.1 Chimeric MABs market, 2014 – 2025 (USD Billion)
5.2.3.3 Humanized MABs
5.2.3.3.1 Humanized MABs market, 2014 – 2025 (USD Billion)
5.2.3.4 Human MABs
5.2.3.4.1 Human MABs market, 2014 – 2025 (USD Billion)
5.2.3.5 Other MABs
5.2.3.5.1 Other MABs market, 2014 – 2025 (USD Billion)
5.3 Vaccines
5.3.1 Global vaccines market, 2014 – 2025 (USD Billion)
5.4 Recombinant Proteins
5.4.1 Global recombinant proteins market, 2014 – 2025 (USD Billion)
5.5 Antisense, RNAi & Molecular Therapy
5.5.1 Global antisense, RNAi & molecular therapy market, 2014 – 2025 (USD Billion)
5.6 Others
5.6.1 Global other product market, 2014 – 2025 (USD Billion)
Chapter 6 Biologics Market: Manufacturing Estimates & Trend Analysis
6.1 Global Biologics Market: Manufacturing Movement Analysis
6.2 Outsourced
6.2.1 Global outsourced market, 2014 – 2025 (USD Billion)
6.3 In-house
6.3.1 Global in-house market, 2014 – 2025 (USD Billion)
Chapter 7 Biologics Market: Disease Category Estimates & Trend Analysis
7.1 Global Biologics Market: Disease Category Movement Analysis
7.2 Oncology
7.2.1 Global oncology market, 2014 – 2025 (USD Billion)
7.2.2 MABs market for oncology
7.2.2.1 Global MABs market for oncology, 2014 – 2025 (USD Billion)
7.2.3 Vaccines market for oncology
7.2.3.1 Global vaccines market for oncology, 2014 – 2025 (USD Billion)
7.2.4 Recombinant proteins market for oncology
7.2.4.1 Global recombinant proteins market for oncology, 2014 – 2025 (USD Billion)
7.2.5 Antisense, RNAi, & molecular therapy market for oncology
7.2.5.1 Global antisense, RNAi, & molecular therapy market for oncology, 2014 – 2025 (USD Billion)
7.2.6 Other products market for oncology
7.2.6.1 Global products market for oncology, 2014 – 2025 (USD Billion)
7.3 Infectious Disease
7.3.1 Global infectious disease market, 2014 – 2025 (USD Billion)
7.3.2 Vaccines market for infectious disease
7.3.2.1 Global vaccines market for infectious disease, 2014 – 2025 (USD Billion)
7.3.3 MABs market for infectious disease
7.3.3.1 Global MABs market for infectious disease, 2014 – 2025 (USD Billion)
7.3.4 Antisense, RNAi, & molecular therapy market for infectious disease
7.3.4.1 Global antisense, RNAi, & molecular therapy market for infectious disease, 2014 – 2025 (USD Billion)
7.3.5 Recombinant proteins market for infectious disease
7.3.5.1 Global recombinant proteins market for infectious disease, 2014 – 2025 (USD Billion)
7.3.6 Other products market for infectious disease
7.3.6.1 Global products market for infectious disease, 2014 – 2025 (USD Billion)
7.4 Immunological Disorders
7.4.1 Global immunological disorders market, 2014 – 2025 (USD Billion)
7.5 Cardiovascular disorders
7.5.1 Global cardiovascular disorders market, 2014 – 2025 (USD Billion)
7.6 Hematologic Disorders
7.6.1 Global hematologic disorders market, 2014 – 2025 (USD Billion)
7.7 Others
7.7.1 Global other indications market, 2014 – 2025 (USD Billion)
Chapter 8 Biologics Market: Regional Estimates & Trend Analysis, by Source, Product, Manufacturing, & Disease Category
8.1 Biologics Market Share By Region, 2015 & 2025
8.2 North America
8.2.1 North America biologics market, 2014 – 2025 (USD Billion)
8.2.2 U.S.
8.2.2.1 U.S. biologics market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada biologics market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe biologics market, 2014 – 2025 (USD Billion)
8.3.2 Germany
8.3.2.1 Germany biologics market, 2014 – 2025 (USD Billion)
8.3.3 UK
8.3.3.1 UK biologics market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific biologics market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan biologics market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China biologics market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America biologics market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil biologics market, 2014 – 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa biologics market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa biologics market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Samsung BioLogics
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Amgen
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Novo Nordisk A/S
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 AbbVie Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Sanofi
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Johnson & Johnson Services, Inc
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Pfizer Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Merck & Co., Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.9 GSK group of companies
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Celltrion
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Precision Biologics, Inc.
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Merck KGaA
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Eli Lilly and Company
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 Novartis AG
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 Bayer AG
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 F. Hoffmann-La Roche Ltd
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 AstraZeneca
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
【レポート販売概要】
■ タイトル：生物製剤の世界市場分析：由来別（微生物、哺乳類）、製品別（モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi、分子治療）、病気の種類別、製造法別、セグメント予測、2014-2025■ 英文：Biologics Market Analysis By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy), By Disease Category, By Manufacturing, And Segment Forecasts, 2014-2025
■ 発行日：2017年3月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707122
■ 調査対象地域：グローバル
- Liver Fibrosis：グローバル臨床試験レビューH2, 2013Liver Fibrosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per …
- Enteric Diseases in Italy 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals and Commercial/Priv …
- 凍結治療の世界市場2019-2023About Cryotherapy Cryotherapy is a cold therapy and used for the treatment of pain by using freezing temperatures on a localized region of the body to eliminate an irritated nerve. Cryotherapy is also being increasingly adopted by dermatologists to treat abnormal skin cells. Technavio’s analysts forecast the Global Cryotherapy Market to grow at a CAGR of 8.45% during the period 2019-2023. Covered …
- 世界の避雷器市場2015The Global Lightning Arrester Industry Report 2015 is a professional and in-depth study on the current state of the Lightning Arrester industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Lightning Arrester market analysis is provided for the international markets including development trends, competit …
- 世界の亜硫酸ガス市場2015The Global Sulfur Dioxide Industry Report 2015 is a professional and in-depth study on the current state of the Sulfur Dioxide industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sulfur Dioxide market analysis is provided for the international markets including development trends, competitive landscape …
- SEX関連用品の世界市場2015-2019About Sexual Wellness Sexual wellness is a term used to describe the enhancement of sexual health and experience. Sexual wellness products include condoms, sensual lingerie, pleasure-enhancing devices, lubricants, toys, contraceptives, costumes, accessories, adult games, oils, and herbal supplements. These products are used for sexual wellbeing, to enhance pleasure, and to induce an element of adv …
- 世界小売産業におけるビジネスインテリジェンス市場：Global Business Intelligence (BI) Market in Retail Industry 2014-2018TechNavio's analysts forecast the Global BI market in the Retail industry to grow at a CAGR of 9.19 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing volume of information generated in the Retail industry. The Global BI market in the Retail industry has also been witnessing the shift towards predictive analytic tools. However, the high c …
- 飼料添加剤の世界市場予測（～2022年）“Feed additives market is projected to grow at a CAGR of 4.5% during the forecast period.”The feed additives market is estimated at USD 22.62 billion in 2017 and is projected to grow at a CAGR of 4.5%, to reach USD 28.22 billion by 2022. The main factors that drive the demand for feed additives include the growth in consumption of animal-based products, growth in feed production, standardization o …
- スキンケア化粧品の世界市場2019-2023About this market In recent years, the population in the age group of 30-45 years has been increasing worldwide. This is leading to growing demand for cosmetic skincare products to achieve flawless looking skin while improving the person’s overall appearance. The aging anxiety, environmental factors, concerns about changes in facial appearance, and the need to look younger have all led middle-aged …
- 世界の光検出・測距（LiDAR）市場分析及び予測The term 'LiDAR' is an acronym for 'Light Detection and Ranging', which has been derived from the common term 'RADAR'. LiDAR technology has been around in the military and research circles since the early 1950s. A typical LiDAR system mainly consists of three major components: a laser sensor, a Global Positioning System (GPS) unit, and an inertial navigation unit. The LiDAR system sends out laser …
- ディスクリート・ダイオードの世界市場2017-2021About Discrete DiodeThe discrete diodes are semiconductor components that allow the current to pass from one direction (with zero resistance) and not from another direction (offering almost infinite resistance). Technavio’s analysts forecast the global discrete diode market to grow at a CAGR of 4.6% during the period 2017-2021. [Covered in this report] The report covers the present scenario and th …
- ラボ用濾過の世界市場：精密濾過、限外濾過、逆浸透膜About Filtration Filtration is a method used to separate or collect a desired solid from a solution, or to remove solid impurities from a liquid. This process is done by passing a contaminated fluid through a membrane, filter paper or any other filtration media, and the pure desired filtrate is obtained on the other end. The filtration media often have a large number of pores of different sizes to …
- 2014年戦略提言：日本の内分泌機能検査市場This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Japanese endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Es …
- Candidiasis：グローバル臨床試験レビューH1, 2013Candidiasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2013" provides data on the Candidiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Candidiasis. It includes an overview of the trial numbers and their recruitment status as per the site of …
- 自動車窓および外部密封システムの世界市場予測（～2021）：部品種類別（ガラスランチャンネル、ルーフモール、外装シール（前面ガラス、フードシール、トランクシール））、車両別（乗用車PC、小型商用車LCV、重型商用車HCV、電気自動車EV）、地域別“The global increase in vehicle production of fastest developing countries and developed countries gives the thrust for automotive sealant growth”The automotive window and exterior sealant market was estimated to be USD 18.26 billion in 2016 and is projected to reach USD 25.69 billion by 2021, with CAGR of 7.07%. The growth mainly contributes from global vehicle production of 92.6 million units in …
